Home Newsfeeds Deutsche Bank Maintains Hold on Livent, Lowers Price Target to $24

Deutsche Bank Maintains Hold on Livent, Lowers Price Target to $24

Deutsche Bank analyst Corinne Blanchard maintains Livent (NYSE:LTHM) with a Hold and lowers the price target from $29 to $24.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Deutsche Bank analyst Corinne Blanchard maintains Livent (NYSE:LTHM) with a Hold and lowers the price target from $29 to $24.

Analyst Ratings

Where Huntsman Stands With Analysts

By Benzinga Insights

September 12, 3:15 PM

Huntsman (NYSE:HUN) has observed the following analyst ratings within the last quarter:

HUN

Usana Health Sciences Q4 EPS $0.66 Beats $0.35 Estimate, Sales $228.00M Beat $203.79M Estimate

By Benzinga Newsdesk

February 7, 5:08 PM

Usana Health Sciences (NYSE:USNA) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.35 by 88.57 percent. This is a 35.92 percent decrease over earnings of $1.03 per share from

USNA

Sangamo Therapeutics Q3 EPS $(0.34) Beats $(0.35) Estimate, Sales $26.46M Miss $26.59M Estimate

By Benzinga Newsdesk

November 3, 4:15 PM

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.35) by 2.86 percent. This is a 3.03 percent decrease over losses of $(0.33) per share

SGMO

Entravision Comms Q4 EPS $(0.02), Sales $296.33M Beat $261.45M Estimate

By Michael Horton

March 9, 5:11 PM

Entravision Comms (NYSE:EVC) reported quarterly losses of $(0.02) per share. This is a 115.38 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of

EVC

Deutsche Bank Maintains Hold on Livent, Lowers Price Target to $24

Related Posts

Where Huntsman Stands With Analysts

Usana Health Sciences Q4 EPS $0.66 Beats $0.35 Estimate, Sales $228.00M Beat $203.79M Estimate

Sangamo Therapeutics Q3 EPS $(0.34) Beats $(0.35) Estimate, Sales $26.46M Miss $26.59M Estimate

Entravision Comms Q4 EPS $(0.02), Sales $296.33M Beat $261.45M Estimate